P21 (P021) vs Selank
Updated September 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of P21 (P021) and Selank (also searched as Selank vs P21 (P021)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
P21 (P021) centers on neuro, while Selank leans toward neuro. On indexed research, P21 (P021) is ahead (P21 (P021): 24 studies, Human evidence; Selank: 22, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •P21 (P021) is strongest for neuro; Selank for neuro.
- •Evidence: P21 (P021) Human evidence (24 studies) vs Selank Human evidence (22).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Neuroprotection | Cognitive decline
Neuroprotection | Anxiolytic and cognitive enhancement
P21 (P021) vs Selank: side-by-side
| Metric | P21 (P021) | Selank |
|---|---|---|
| Class | Neuro | Neuro |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 24 | 22 |
| Research level | Preclinical | Moderate Research |
| Strongest effect | Neuro & mood | Neuro & mood |
| Healing & recovery | 0.0 | 1.0▲ |
| Muscle & body comp | 0.0 | 0.0 |
| Metabolic & appetite | 0.0 | 0.0 |
| Neuro & mood | 4.0▲ | 4.0▲ |
| Sleep & circadian | 0.0 | 1.0▲ |
| Inflammation & immune | 0.0 | 1.0▲ |
| Skin & aesthetics | 0.0 | 0.0 |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | P21 (P021) | Selank |
|---|---|---|
| Mechanism | Modulation of BDNF signaling | Anxiolytic heptapeptide (Tuftsin analog) |
| Route | — | Intranasal / subcutaneous (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is P21 (P021)?
P21 (P021) is a CNTF-derived neurogenic peptide researched preclinically for cognitive decline, tau pathology, and BDNF-mediated neuroprotection. Research-use only with no human trial data.
Full P21 (P021) profile, mechanism & studies →What is Selank?
Selank is a synthetic peptide derived from the naturally occurring peptide tuftsin, primarily studied for its potential anxiolytic and cognitive-enhancing properties. Research into Selank has focused on its effects on neuroprotection, stress response, and cognitive function, although further studies are needed to fully understand its mechanisms and therapeutic applications.
Full Selank profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | Selank | 1.0/5 effect signal |
| Neuro | Even | Both ~4.0/5 |
| Sleep | Selank | 1.0/5 effect signal |
| Inflammation | Selank | 1.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack P21 (P021) and Selank?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
P21 (P021) vs Selank: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
P21 (P021) has 24 approved studies indexed (Human evidence), and Selank has 22 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is P21 (P021) or Selank better?
It depends on your goal. P21 (P021) is strongest for neuro; Selank for neuro. P21 (P021) has more indexed studies (24). See the goal-by-goal breakdown above.
Which has more research, P21 (P021) or Selank?
P21 (P021) has 24 approved studies indexed (Human evidence); Selank has 22 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack P21 (P021) and Selank?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of P21 (P021) vs Selank?
P21 (P021): no community-reported effects logged yet. Selank: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is P21 (P021) or Selank FDA-approved?
P21 (P021) is a research-use compound and is not FDA-approved. Selank is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Selank better than P21 (P021)?
For neuro, Selank has the edge; for neuro, P21 (P021) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
P21 (P021) and Selank are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed September 21, 2026.